Grail股票讨论

$Grail(GRAL.US)$
GRAIL 推进了 Galleri® 注册临床试验计划
GRAIL（纳斯达克股票代码：GRAL）宣布其Galleri® 多癌症早期检测（MCED）测试的临床试验取得重大进展。该公司已经完成了北美PATHFINDER 2研究的35,000多名参与者的入组，并完成了NHS-Galleri试验的最后一次研究访问，该试验在英格兰有超过14万名参与者。前 25,000 名 PATHFINDER 2 参与者的结果...

$Illumina(ILMN.US)$  botched the acquisition of $Grail(GRAL.US)$  after the move was banned by european authorities and has finished divesting as GRAL just opened shop on stock markets very recently as a separate entity from ILMN. with this shareholders might start to pour money back into Illumina which is clearly undervalued by any metric you throw at it it's not a dead business so there's some money to be made here you can look at the chart recently ...

$Grail(GRAL.US)$ 为什么是断路器？